Loading viewer...
conference
Format: PDF conference
Immunovant presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024, showcasing its pipeline of targeted therapies for autoimmune diseases. The presentation discusses the development of batoclimab and IMVT-1402, highlighting their potential as first-in-class or best-in-class candidates across multiple autoimmune indications.
conference
36 Pages
Heritage Crystal Clean, Inc.
Biocon Biologics 2022 Press Meet
conferenceconference
23 Pages
Biocon Biologics